Serologic response to porcine circovirus type 1 (PCV1) in infants vaccinated with the human rotavirus vaccine, Rotarix™: A retrospective laboratory analysis

References

• Tate JE, Patel MM, Steele AD, Gentsch JR, Payne DC, Cortese MM, Nakagomi O, Cunliffe NA, Jiang B, Neuzil KM, et al. Global impact of rotavirus vaccines. Expert Rev Vaccines 2010; 9:395-407; PMID:20370550; http://dx.doi.org/10.1586/erv.10.17
   PubMed Web of Science ®Google Scholar
• Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003; 9:565-72; PMID:12737740; http://dx.doi.org/10.3201/eid0905.020562
   PubMed Web of Science ®Google Scholar
• Parashar UD, Burton A, Lanata C, Boschi-Pinto C, Shibuya K, Steele D, Birmingham M, Glass RI. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 2009; 200 Suppl 1:S9-S15; PMID:19817620; http://dx.doi.org/10.1086/605025
   PubMed Web of Science ®Google Scholar
• WHO. Meeting of the immunization Strategic Advisory Group of Experts, April 2009–conclusions and recommendations. Wkly Epidemiol Rec 2009; 84:220-36; PMID:19499606
   PubMedGoogle Scholar
• Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354:11-22; PMID:16394298; http://dx.doi.org/10.1056/NEJMoa052434
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, Meurice F, Han HH, Damaso S, Bouckenooghe A. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007; 370:1757-63; PMID:18037080; http://dx.doi.org/10.1016/S0140-6736(07)61744-9
   PubMed Web of Science ®Google Scholar
• Linhares AC, Velazquez FR, Perez-Schael I, Saez-Llorens X, Abate H, Espinoza F, Lopez P, Macias-Parra M, Ortega-Barria E, Rivera-Medina DM, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 2008; 371:1181-9; PMID:18395579; http://dx.doi.org/10.1016/S0140-6736(08)60524-3
   PubMed Web of Science ®Google Scholar
• Phua KB, Lim FS, Lau YL, Nelson EA, Huang LM, Quak SH, Lee BW, van Doorn LJ, Teoh YL, Tang H, et al. Rotavirus vaccine RIX4414 efficacy sustained during the third year of life: a randomized clinical trial in an Asian population. Vaccine 2012; 30:4552-7; PMID:22497874; http://dx.doi.org/10.1016/j.vaccine.2012.03.030
   PubMed Web of Science ®Google Scholar
• Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, Ngwira B, Victor JC, Gillard PH, Cheuvart BB, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010; 362:289-98; PMID:20107214; http://dx.doi.org/10.1056/NEJMoa0904797
   PubMed Web of Science ®Google Scholar
• Cunliffe NA, Witte D, Ngwira BM, Todd S, Bostock NJ, Turner AM, Chimpeni P, Victor JC, Steele AD, Bouckenooghe A, et al. Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: a randomized, double-blind, placebo controlled trial. Vaccine 2012; 30 Suppl 1:A36-43; PMID:22520135; http://dx.doi.org/10.1016/j.vaccine.2011.09.120
   PubMed Web of Science ®Google Scholar
• Kawamura N, Tokoeda Y, Oshima M, Okahata H, Tsutsumi H, Van Doorn LJ, Muto H, Smolenov I, Suryakiran PV, Han HH. Efficacy, safety and immunogenicity of RIX4414 in Japanese infants during the first two years of life. Vaccine 2011; 29:6335-41; PMID:21640780; http://dx.doi.org/10.1016/j.vaccine.2011.05.017
   PubMed Web of Science ®Google Scholar
• Li RC, Huang T, Li Y, Luo D, Tao J, Fu B, Si G, Nong Y, Mo Z, Liao X, et al. Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: a randomized, placebo-controlled trial in China. Hum Vaccin Immunother 2014; 10:11-8; PMID:24013441; http://dx.doi.org/10.4161/hv.26319
   PubMed Web of Science ®Google Scholar
• Richardson V, Parashar U, Patel M. Childhood diarrhea deaths after rotavirus vaccination in Mexico. N Engl J Med 2011; 365:772-3; PMID:21864191; http://dx.doi.org/10.1056/NEJMc1100062
   PubMed Web of Science ®Google Scholar
• Braeckman T, Van Herck K, Meyer N, Pircon JY, Soriano-Gabarro M, Heylen E, Zeller M, Azou M, Capiau H, De Koster J, et al. Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study. BMJ 2012; 345:e4752; PMID:22875947; http://dx.doi.org/10.1136/bmj.e4752
   PubMed Web of Science ®Google Scholar
• Paulke-Korinek M, Kollaritsch H, Aberle SW, Zwazl I, Schmidle-Loss B, Vecsei A, Kundi M. Sustained low hospitalization rates after four years of rotavirus mass vaccination in Austria. Vaccine 2013; 31:2686-91; PMID:23597718; http://dx.doi.org/10.1016/j.vaccine.2013.04.001
   PubMed Web of Science ®Google Scholar
• Pendleton A, Galic M, Clarke C, Ng SP, Ledesma E, Ramakrishnan G, Liu Y. Impact of rotavirus vaccination in Australian children below 5 years of age: a database study. Hum Vaccin Immunother 2013; 9:1617-25; PMID:23733041; http://dx.doi.org/10.4161/hv.24831
   PubMed Web of Science ®Google Scholar
• Rha B, Tate JE, Payne DC, Cortese MM, Lopman BA, Curns AT, Parashar UD. Effectiveness and impact of rotavirus vaccines in the United States - 2006-2012. Expert Rev Vaccines 2014; 13:365-76; PMID:24392657; http://dx.doi.org/10.1586/14760584.2014.877846
   PubMed Web of Science ®Google Scholar
• de Oliveira LH, Camacho LA, Coutinho ES, Ruiz-Matus C, Leite JP. Rotavirus vaccine effectiveness in Latin American and Caribbean countries: A systematic review and meta-analysis. Vaccine 2015; 33 Suppl 1:A248-54; PMID:25919169; http://dx.doi.org/10.1016/j.vaccine.2014.11.060
   PubMedGoogle Scholar
• O'Ryan M, Giaquinto C, Benninghoff B. Human rotavirus vaccine (Rotarix): focus on effectiveness and impact 6 years after first introduction in Africa. Expert Rev Vaccines 2015; 14:1099-112; PMID:26098566; http://dx.doi.org/10.1586/14760584.2015.1059282
   PubMed Web of Science ®Google Scholar
• Bar-Zeev N, Kapanda L, Tate JE, Jere KC, Iturriza-Gomara M, Nakagomi O, Mwansambo C, Costello A, Parashar UD, Heyderman RS, et al. Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study. Lancet Infect Dis 2015; 15:422-8; PMID:25638521; http://dx.doi.org/10.1016/S1473-3099(14)71060-6
   PubMed Web of Science ®Google Scholar
• Victoria JG, Wang C, Jones MS, Jaing C, McLoughlin K, Gardner S, Delwart EL. Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus. J Virol 2010; 84:6033-40; PMID:20375174; http://dx.doi.org/10.1128/JVI.02690-09
   PubMed Web of Science ®Google Scholar
• Allan GM, Ellis JA. Porcine circoviruses: a review. J Vet Diagn Invest 2000; 12:3-14; PMID:10690769; http://dx.doi.org/10.1177/104063870001200102
   PubMed Web of Science ®Google Scholar
• Tischer I, Rasch R, Tochtermann G. Characterization of papovavirus-and picornavirus-like particles in permanent pig kidney cell lines. Zentralbl Bakteriol Orig A 1974; 226:153-67; PMID:4151202
   PubMedGoogle Scholar
• Tischer I, Gelderblom H, Vettermann W, Koch MA. A very small porcine virus with circular single-stranded DNA. Nature 1982; 295:64-6; PMID:7057875; http://dx.doi.org/10.1038/295064a0
   PubMed Web of Science ®Google Scholar
• Tischer I, Mields W, Wolff D, Vagt M, Griem W. Studies on epidemiology and pathogenicity of porcine circovirus. Arch Virol 1986; 91:271-6; PMID:3778212; http://dx.doi.org/10.1007/BF01314286
   PubMed Web of Science ®Google Scholar
• Ramamoorthy S, Meng XJ. Porcine circoviruses: a minuscule yet mammoth paradox. Anim Health Res Rev 2009; 10:1-20; PMID:18761774; http://dx.doi.org/10.1017/S1466252308001461
   PubMedGoogle Scholar
• Li L, Kapoor A, Slikas B, Bamidele OS, Wang C, Shaukat S, Masroor MA, Wilson ML, Ndjango JB, Peeters M, et al. Multiple diverse circoviruses infect farm animals and are commonly found in human and chimpanzee feces. J Virol 2010; 84:1674-82; PMID:20007276; http://dx.doi.org/10.1128/JVI.02109-09
   PubMed Web of Science ®Google Scholar
• Blinkova O, Rosario K, Li L, Kapoor A, Slikas B, Bernardin F, Breitbart M, Delwart E. Frequent detection of highly diverse variants of cardiovirus, cosavirus, bocavirus, and circovirus in sewage samples collected in the United States. J Clin Microbiol 2009; 47:3507-13; PMID:19794058; http://dx.doi.org/10.1128/JCM.01062-09
   PubMed Web of Science ®Google Scholar
• World Health Organization. Questions and answers relating to finding of porcine circoviruses in rotavirus vaccines (2010). Available at: http://www.who.int/immunization_standards/vaccine_quality/PCV1_Q_and_As_rotavirus_vaccines_3Jun10.pdf Accessed on: February 4, 2016
   Google Scholar
• Dubin G, Toussaint JF, Cassart JP, Howe B, Boyce D, Friedland L, Abu-Elyazeed R, Poncelet S, Han HH, Debrus S. Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine, Rotarix: approach and outcome. Hum Vaccin Immunother 2013; 9:2398-408; PMID:24056737; http://dx.doi.org/10.4161/hv.25973
   PubMed Web of Science ®Google Scholar
• Hattermann K, Roedner C, Schmitt C, Finsterbusch T, Steinfeldt T, Mankertz A. Infection studies on human cell lines with porcine circovirus type 1 and porcine circovirus type 2. Xenotransplantation 2004; 11:284-94; PMID:15099209; http://dx.doi.org/10.1111/j.1399-3089.2004.00134.x
   PubMed Web of Science ®Google Scholar
• Ranucci CS, Tagmyer T, Duncan P. Adventitious Agent Risk Assessment Case Study: Evaluation of RotaTeq(R) for the Presence of Porcine Circovirus. PDA J Pharm Sci Technol 2011; 65:589-98; PMID:22294581; http://dx.doi.org/10.5731/pdajpst.2011.00827
   PubMedGoogle Scholar
• Krakowka S, Ellis JA, Meehan B, Kennedy S, McNeilly F, Allan G. Viral wasting syndrome of swine: experimental reproduction of postweaning multisystemic wasting syndrome in gnotobiotic swine by coinfection with porcine circovirus 2 and porcine parvovirus. Vet Pathol 2000; 37:254-63; PMID:10810990; http://dx.doi.org/10.1354/vp.37-3-254
   PubMed Web of Science ®Google Scholar
• Opriessnig T, Halbur PG. Concurrent infections are important for expression of porcine circovirus associated disease. Virus Res 2012; 164:20-32; PMID:21959087; http://dx.doi.org/10.1016/j.virusres.2011.09.014
   PubMed Web of Science ®Google Scholar
• Segales J. Porcine circovirus type 2 (PCV2) infections: clinical signs, pathology and laboratory diagnosis. Virus Res 2012; 164:10-9; PMID:22056845; http://dx.doi.org/10.1016/j.virusres.2011.10.007
   PubMed Web of Science ®Google Scholar
• Ellis JA, Wiseman BM, Allan G, Konoby C, Krakowka S, Meehan BM, McNeilly F. Analysis of seroconversion to porcine circovirus 2 among veterinarians from the United States and Canada. J Am Vet Med Assoc 2000; 217:1645-6; PMID:11110452; http://dx.doi.org/10.2460/javma.2000.217.1645
   PubMed Web of Science ®Google Scholar
• Hattermann K, Maerz A, Slanina H, Schmitt C, Mankertz A. Assessing the risk potential of porcine circoviruses for xenotransplantation: consensus primer-PCR-based search for a human circovirus. Xenotransplantation 2004; 11:547-50; PMID:15479465; http://dx.doi.org/10.1111/j.1399-3089.2004.00181.x
   PubMed Web of Science ®Google Scholar
• Delwart E, Li L. Rapidly expanding genetic diversity and host range of the Circoviridae viral family and other Rep encoding small circular ssDNA genomes. Virus Res 2012; 164:114-21; PMID:22155583; http://dx.doi.org/10.1016/j.virusres.2011.11.021
   PubMed Web of Science ®Google Scholar
• Arnold F, Hober D, Chaussade H, Dumarest M, Sane F, Nowakowsjki M, Rigaud E, Bellalou J, Desailloud R, Coursaget P, et al. Antibodies to VP1 of swine pasivirus in humans without evidence of transmission from a pig source. J Clin Virol 2015; 69:36-9; PMID:26209375; http://dx.doi.org/10.1016/j.jcv.2015.05.026
   PubMed Web of Science ®Google Scholar
• Buehring GC, Philpott SM, Choi KY. Humans have antibodies reactive with Bovine leukemia virus. AIDS Res Hum Retroviruses 2003; 19:1105-13; PMID:14709247; http://dx.doi.org/10.1089/088922203771881202
   PubMed Web of Science ®Google Scholar
• Liu R, Vaishnav RA, Roberts AM, Friedland RP. Humans have antibodies against a plant virus: evidence from tobacco mosaic virus. PLoS One 2013; 8:e60621; PMID:23573274; http://dx.doi.org/10.1371/journal.pone.0060621
   PubMed Web of Science ®Google Scholar
• Dulac GC, Afshar A. Porcine circovirus antigens in PK-15 cell line (ATCC CCL-33) and evidence of antibodies to circovirus in Canadian pigs. Can J Vet Res 1989; 53:431-3; PMID:2686830
   PubMed Web of Science ®Google Scholar
• Tischer I, Bode L, Peters D, Pociuli S, Germann B. Distribution of antibodies to porcine circovirus in swine populations of different breeding farms. Arch Virol 1995; 140:737-43; PMID:7794114; http://dx.doi.org/10.1007/BF01309961
   PubMed Web of Science ®Google Scholar
• Raye W, Muhling J, Warfe L, Buddle JR, Palmer C, Wilcox GE. The detection of porcine circovirus in the Australian pig herd. Aust Vet J 2005; 83:300-4; PMID:15957393; http://dx.doi.org/10.1111/j.1751-0813.2005.tb12747.x
   PubMed Web of Science ®Google Scholar
• Beach NM, Cordoba L, Kenney SP, Meng XJ. Productive infection of human hepatocellular carcinoma cells by porcine circovirus type 1. Vaccine 2011; 29:7303-6; PMID:21742002; http://dx.doi.org/10.1016/j.vaccine.2011.06.097
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration (FDA). US Department of Health and Human Services. Guidance for Industry: “Characterization and Qualification of cell Substrates and other biological materials used in the production of viral vaccines for infectious disease Indications” (2010). Available at: http://www.fda.gov/downloads/biologicsbloodvaccines/guidancecomplianceregulatoryinformation/guidances/vaccines/ucm202439.pdf Accessed on: June 27, 2016
   Google Scholar
• Veerasami M, Chitra K, Mohana Subramanian B, Thamaraikannan P, Srinivasan V. Individual and Multiplex PCR Assays for the Detection of Adventitious Bovine and Porcine Viral Genome Contaminants in the Commercial Vaccines and Animal Derived Raw Materials. J Veterinar Sci Technol 2014; 5:179; http://dx.doi.org/10.4172/2157-7579.1000179
   Google Scholar
• Bruhn S, Bruckner L, Ottiger HP. Application of RT-PCR for the detection of avian reovirus contamination in avian viral vaccines. J Virol Methods 2005; 123:179-86; PMID:15620400; http://dx.doi.org/10.1016/j.jviromet.2004.09.019
   PubMed Web of Science ®Google Scholar
• Studer E, Bertoni G, Candrian U. Detection and characterization of pestivirus contaminations in human live viral vaccines. Biologicals 2002; 30:289-96; PMID:12421586; http://dx.doi.org/10.1006/biol.2002.0343
   PubMed Web of Science ®Google Scholar
• Engels EA. Cancer risk associated with receipt of vaccines contaminated with simian virus 40: epidemiologic research. Expert Rev Vaccines 2005; 4:197-206; PMID:15889993; http://dx.doi.org/10.1586/14760584.4.2.197
   PubMed Web of Science ®Google Scholar
• Hussain AI, Johnson JA, Da Silva Freire M, Heneine W. Identification and characterization of avian retroviruses in chicken embryo-derived yellow fever vaccines: investigation of transmission to vaccine recipients. J Virol 2003; 77:1105-11; PMID:12502826; http://dx.doi.org/10.1128/JVI.77.2.1105-1111.2003
   PubMed Web of Science ®Google Scholar
• Hussain AI, Shanmugam V, Switzer WM, Tsang SX, Fadly A, Thea D, Helfand R, Bellini WJ, Folks TM, Heneine W. Lack of evidence of endogenous avian leukosis virus and endogenous avian retrovirus transmission to measles, mumps, and rubella vaccine recipients. Emerg Infect Dis 2001; 7:66-72; PMID:11266296; http://dx.doi.org/10.3201/eid0701.010111
   PubMed Web of Science ®Google Scholar
• Buyse H, Vinals C, Karkada N, Han HH. The human rotavirus vaccine Rotarix in infants: an integrated analysis of safety and reactogenicity. Hum Vaccin Immunother 2014; 10:19-24; PMID:24047799; http://dx.doi.org/10.4161/hv.26476
   PubMed Web of Science ®Google Scholar
• Bravo L, Chitraka A, Liu A, Choudhury J, Kumar K, Berezo L, Cimafranca L, Chatterjee P, Garg P, Siriwardene P, et al. Reactogenicity and safety of the human rotavirus vaccine, Rotarix in The Philippines, Sri Lanka, and India: a post-marketing surveillance study. Hum Vaccin Immunother 2014; 10:2276-83; PMID:25424932; http://dx.doi.org/10.4161/hv.29280
   PubMed Web of Science ®Google Scholar
• Carlin JB, Macartney KK, Lee KJ, Quinn HE, Buttery J, Lopert R, Bines J, McIntyre PB. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program. Clin Infect Dis 2013; 57:1427-34; PMID:23964090; http://dx.doi.org/10.1093/cid/cit520
   PubMed Web of Science ®Google Scholar
• Patel MM, Lopez-Collada VR, Bulhoes MM, De Oliveira LH, Bautista Marquez A, Flannery B, Esparza-Aguilar M, Montenegro Renoiner EI, Luna-Cruz ME, Sato HK, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med 2011; 364:2283-92; PMID:21675888; http://dx.doi.org/10.1056/NEJMoa1012952
   PubMed Web of Science ®Google Scholar
• Dennehy PH, Brady RC, Halperin SA, Ward RL, Alvey JC, Fischer FH, Jr., Innis BL, Rathfon H, Schuind A, De Vos B. Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine. Pediatr Infect Dis J 2005; 24:481-8; PMID:15933555; http://dx.doi.org/10.1097/01.inf.0000164763.55558.71
   PubMed Web of Science ®Google Scholar
• Phua KB, Lim FS, Lau YL, Nelson EA, Huang LM, Quak SH, Lee BW, Teoh YL, Tang H, Boudville I, et al. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study. Vaccine 2009; 27:5936-41; PMID:19679216; http://dx.doi.org/10.1016/j.vaccine.2009.07.098
   PubMed Web of Science ®Google Scholar
• Omenaca F, Sarlangue J, Szenborn L, Nogueira M, Suryakiran PV, Smolenov IV, Han HH. Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European Infants: a randomized phase IIIb study. Pediatr Infect Dis J 2012; 31:487-93; PMID:22228231; http://dx.doi.org/10.1097/INF.0b013e3182490a2c
   PubMed Web of Science ®Google Scholar
• Clopper CJ, ES P. The use of confidence of fiducial limits illustrated in the case of the binomial. Biometrika 1934; 26:10; http://dx.doi.org/10.1093/biomet/26.4.404
   Google Scholar
• Newcombe RG. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med 1998; 17:873-90; PMID:9595617; http://dx.doi.org/10.1002/(SICI)1097-0258(19980430)17:8%3c873::AID-SIM779%3e3.0.CO;2-I
   PubMed Web of Science ®Google Scholar